Venn Life Sciences (LON:VENN) Shares Pass Above 200 Day Moving Average – Here’s Why

Shares of Venn Life Sciences Holdings PLC (LON:VENN) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 6.85 ($0.09) and traded as high as GBX 7 ($0.09). Venn Life Sciences shares last traded at GBX 6.85 ($0.09), with a volume of 1,027,544 shares trading hands.

Venn Life Sciences Stock Performance

The stock’s 50-day moving average price is GBX 6.85 and its 200 day moving average price is GBX 6.85. The company has a quick ratio of 1.48, a current ratio of 2.30 and a debt-to-equity ratio of 35.83. The company has a market cap of £4.89 million and a P/E ratio of -2.14.

About Venn Life Sciences

Venn Life Sciences Holdings Plc, a clinical research organization, provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device companies in the United Kingdom, Ireland, France, the Netherlands, Germany, and Singapore. The company offers drug development planning and strategy services, including clinical feasibility assessment, project management, and in-licensing and technical due diligence; and early drug development services, such as drug candidate selection, CMC, non-clinical/pre-clinical development, clinical pharmacology, pharmacokinetics, and pharmacometrics and PK-PD modelling.